Fluvastatin
Fluvastatin
CLINICAL USE
HMG CoA reductase inhibitor:Primary hypercholesterolaemia Slowing progression of atherosclerosis Secondary prevention of coronary events after percutaneous coronary intervention
DOSE IN NORMAL RENAL FUNCTION
20–80 mg daily in the eveningXL: 80 mg daily
PHARMACOKINETICS
Molecular weight                           :433.4 (as sodium salt) %Protein binding                           :>98 %Excreted unchanged in urine     : 6 Volume of distribution (L/kg)       :0.35half-life – normal/ESRD (hrs)      :1.4–3.2/– DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Removal unlikely. Dose as in normal renal function HD                     :Removal unlikely. Dose as in normal renal functionHDF/high flux   :Removal unlikely. Dose as in normal renal functionCAV/VVHD      :Removal unlikely. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAntibacterials: rifampicin increases metabolism; increased risk of myopathy with daptomycinAnticoagulants: anticoagulant effect enhancedCiclosporin: concomitant treatment with ciclosporin may lead to risk of muscle toxicityColchicine: isolated cases of myopathy have been reportedLipid-lowering drugs: increased risk of myopathy with gemfibrozil, fibrates and nicotinic acid – avoid concomitant use with gemfibrozil ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
– OTHER INFORMATION
The Committee on Safety of Medicines has advised that rhabdomyolysis associated with lipid-lowering drugs, such as the fibrates and statins, appears to be rare (approx. 1 case in every 100 000 treatment years), but may be increased in those with renal impairment and possibly in those with hypothyroidismManufacturer’s literature indicates fluvastatin is contraindicated in patients with severe renal impairment (creatinine greater than or equal to 160 µmol/L).
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home